Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial.
Year: 2008
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Seoul National University Hospital, Veterans Health Service Medical Center, Pusan National University, National Cancer Center, Ajou University, Korea Institute of Radiological and Medical Sciences, Inha University Hospital, Samsung Medical Center, Daegu Fatima Hospital, Gachon University Gil Medical Center, Chung-Ang University Hospital, Yonsei University, Severance Hospital, Yonsei University Health System, Ewha Womans University, Ewha Womans University Seoul Hospital, Kyungpook National University Hospital, Asan Medical Center, Soonchunhyang University Hospital Seoul
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2981054797